New research identifies an epigenetic cause for why patients with temporal lobe epilepsy tend to have memory loss, and suggests a potential way to reverse that loss.
Four of the most world renowned scholars and influential leaders in the field of infectious disease research will come to UAB to honor the legacy of the late Distinguished Professor Charles Alford, M.D.
UAB researchers find a chemical pathway — a glutamate transporter — that may be causing seizures and shorten survival rates for patients with brain tumors.
Four projects were awarded through the first School of Medicine AMC21 Reload Multi-Investigator Grants, a broad funding opportunity provided through the Academic Enrichment Fund that enables faculty members to organize and integrate multi-disciplinary teams of accomplished investigators to compete successfully for long-term extramural support.
The UAB Center for Clinical and Translational Science (CCTS) is one of 62 centers nationwide making up the Consortium of centers supported by a Clinical & Translational Science Award distributed by the National Institutes of Health.
UAB’s research links changes in genetic regions in infants with an increased risk of premature birth — and the data change the preterm paradigm.
Five faculty members in the UAB School of Medicine have been named the inaugural James A. Pittman Jr., M.D., Scholars, a new program organized to recognize the contributions of junior faculty.
A ramped-up immune response may play a major role in autism disorders, according to a new study from UAB and Johns Hopkins.
A new UAB study reports on a potential new treatment for frontotemporal dementia, the second most common type after Alzheimer’s disease.
The multi-project research targets key molecular steps of immune cell-fate decisions after virus infection.